Abstract

Psoriasis is a chronic inflammatory skin disease that affects approximately 125 million people worldwide. It has significant impacts on both physical and emotional health-related quality of life comparable to other major illnesses. Accurately prediction of psoriasis using biomarkers from routine laboratory tests has important practical values. Our goal is to derive a powerful predictive model for psoriasis disease based on only routine hospital tests. We collected a data set including 466 psoriasis patients and 520 healthy controls with 81 variables from only laboratory routine tests, such as age, total cholesterol, HDL cholesterol, blood pressure, albumin, and platelet distribution width. In this study, Boruta feature selection method was applied to select the most relevant features, with which a Random Forest model was constructed. The model was tested with 30 repetitions of 10-fold cross-validation. Our classification model yielded an average accuracy of 86.9%. 26 notable features were selected by Boruta, among which 15 features are confirmed from previous studies, and the rest are worth further investigations. The experimental results demonstrate that the machine learning approach has good potential in predictive modeling for the psoriasis disease given the information only from routine hospital tests.

Highlights

  • Psoriasis is a systemic, immunological, genetic, chronic inflammatory disease manifesting in the skin or joints

  • The Random Forest model with the best classification performance by hyperparameter turning has the following configuration: the number of trees is set to 500; the number of features to consider when looking for the best split is set to 5; the minimum number of samples required to be at a leaf node is set to 1; the minimum number of samples required to split an internal node is set to 0

  • Since no clinically useful biomarker for psoriasis and its comorbidities has been established so far, we examined 81 biomarkers from routine laboratory tests, and 26 of them were deemed as significantly relevant to psoriasis, based on the procedure described in feature selection section

Read more

Summary

Introduction

Immunological, genetic, chronic inflammatory disease manifesting in the skin or joints. It is characterized by disfigurement and a long clinical course with remissions and relapses, adversely affecting the quality of patients’ life. The skin is the most mainly involved, but it is widely presumed that psoriasis is a multisystemic disorder, frequently accompanied by comorbidities, including cardiac, renal, and metabolic manifestations [3]. Practical and reliable biomarkers that can indicate psoriasis activity and the potentiality of systemic comorbidities will greatly help reduce variation in diagnosis, improve the outcomes of treatment for patients, and reduce the workload for clinicians. We proposed a procedure for predicting whether a patient is with or without psoriasis using routine laboratory tests, which can lead to efficient and repeatable psoriasis diagnosis

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call